Sugi Predict

Sugi Predict / Compounds / SCHEMBL732145

SCHEMBL732145

SCHEMBL732145

CCCCCC(O)C(C=O)CCCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.46
▸ TRPA1 O75762 1/20 0.46
▸ DDAH1 O94760 1/20 0.46
▸ GAPDH P04406 1/20 0.46
▸ SPHK1 Q9NYA1 2/20 0.45
▸ TSHR P16473 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ CYP2D6 P10635 2/20 0.42
▸ GMNN O75496 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ THPO P40225 1/20 0.42
▸ MTOR P42345 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CETP P11597 1/20 0.42
▸ HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9833481 0.96 SPHK1 (0.50) MAPTTRPA1DDAH1GAPDHSPHK1
SCHEMBL6354275 0.96 SPHK1 (0.50) MAPTTRPA1DDAH1GAPDHSPHK1
SCHEMBL9487089 0.96 SPHK1 (0.50) MAPTTRPA1DDAH1GAPDHSPHK1
SCHEMBL25422946 0.90 MAPT (0.42) MAPTTRPA1DDAH1GAPDHSPHK1
SCHEMBL6358091 0.89 TSHR (0.45) MAPTTRPA1DDAH1GAPDHSPHK1
SCHEMBL24053312 0.86 SPHK1 (0.48) MAPTTRPA1DDAH1GAPDHSPHK1
SCHEMBL6445059 0.86 GPR84 (0.46) MAPTTRPA1DDAH1GAPDHSPHK1
SCHEMBL9254171 0.85 TSHR (0.50) MAPTTRPA1DDAH1GAPDHSPHK1
SCHEMBL28229871 0.83 TRPA1 (0.48) MAPTTRPA1DDAH1GAPDHSPHK1
SCHEMBL6030603 0.80 ADH1B (0.50) MAPTTRPA1DDAH1GAPDHTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4711010-A2 PRO-PERFUME COMPOSITIONS Firmenich SA (CH) 2026-03-18 — — EP disclosed
US-20250263631-A1 PRO-PERFUME COMPOSITIONS FIRMENICH SA (CH) 2025-08-21 — — US disclosed
US-12325839-B2 Pro-perfume compositions FIRMENICH SA (CH) 2025-06-10 — — US disclosed
US-20230024269-A1 Pro-Perfume Compositions FIRMENICH SA (CH) 2023-01-26 — — US disclosed
EP-4034073-A1 PRO-PERFUME COMPOSITIONS Firmenich SA (CH) 2022-08-03 — — EP disclosed
CN-114727924-A Pro-fragrance compositions 弗门尼舍有限公司 2022-07-08 — — CN disclosed
WO-2021123144-A1 PRO-PERFUME COMPOSITIONS FIRMENICH SA (CH) 2021-06-24 — — WO disclosed
US-20120142081-A1 BIOSYNTHESIS OF COMMODITY CHEMICALS BIO ARCHITECTURE LAB, INC. (US) 2012-06-07 — — US disclosed
US-8137949-B2 Biosynthesis of commodity chemicals BIO ARCHITECTURE LAB, INC. (US) 2012-03-20 — — US disclosed
US-20110287521-A1 BIOSYNTHESIS OF COMMODITY CHEMICALS BIO ARCHITECTURE LAB, INC. (US) 2011-11-24 — — US disclosed
EP-2361310-A2 BIOSYNTHESIS OF COMMODITY CHEMICALS Bio Architecture Lab, Inc. (US) 2011-08-31 — — EP disclosed
US-8003365-B2 converting sugars and polysaccharides, as well as various aldehydes and/or ketones, into commodity chemicals, such as biofuels isooctane, 2-ethylhexane, and 2-butyloctane; recombinant microorganisms; biofuel blends with petroleum fuels BIO ARCHITECTURE LAB, INC. (US) 2011-08-23 — — US disclosed
US-20100185017-A1 BIOSYNTHESIS OF COMMODITY CHEMICALS BIO ARCHITECTURE LAB, INC. 2010-07-22 — — US disclosed
WO-2010068921-A2 BIOSYNTHESIS OF COMMODITY CHEMICALS BIO ARCHITECTURE LAB, INC. (US) 2010-06-17 — — WO disclosed
US-20050026998-A1 Compounds for the controlled release of active aldehydes FIRMENICH SA (CH) 2005-02-03 — — US disclosed
EP-1487815-A1 COMPOUNDS FOR THE CONTROLLED RELEASE OF ACTIVE ALDEHYDES FIRMENICH SA (CH) 2004-12-22 — — EP disclosed
WO-2003082850-A1 COMPOUNDS FOR THE CONTROLLED RELEASE OF ACTIVE ALDEHYDES FIRMENICH SA (CH) 2003-10-09 — — WO disclosed
EP-0274075-B1 POLYVINYL ACETAL, LIGHT-SENSITIVE COMPOSITION CONTAINING IT AND REPRODUCTION MATERIAL MADE THEREFROM HOECHST AKTIENGESELLSCHAFT (DE) 1993-05-26 — — EP disclosed
US-4940646-A Polyvinyl acetal with hydroxy aliphatic acetal groups useful in photosensitive negative working compositions HOECHST AKTIENGESELLSCHAFT (DE) 1990-07-10 — — US disclosed
EP-0274075-A2 Polyvinyl acetal, light-sensitive composition containing it and reproduction material made therefrom HOECHST AKTIENGESELLSCHAFT (DE) 1988-07-13 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026998-A1 Compounds for the controlled release of active aldehydes ALDH1A1, ADH5, ALDH16A1 MAPT 3670/4885TRPA1 140/4885DDAH1 1391/4885
US-20100185017-A1 BIOSYNTHESIS OF COMMODITY CHEMICALS COASY, HSD17B14, FASN MAPT 2923/4885TRPA1 3319/4885DDAH1 2112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.